Platelet activity in vivo in hyperlipoproteinemia - Importance of combined hyperlipidemia

Thrombosis and Haemostasis

Volumn 79, Issue 2, 1998, Pages 268-275

  Bröijersén, Anders ^a   Hamsten, Anders ^a   Eriksson, Mats ^b   Angelin, Bo ^b   Hjemdahl, Paul ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

11 OXOTHROMBOXANE B2; BETA THROMBOGLOBULIN; FIBRINOGEN; LIPOPROTEIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL ACTIVITY; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; FIBRINOGEN BLOOD LEVEL; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERLIPOPROTEINEMIA; LEUKOCYTE COUNT; LIPOPROTEIN BLOOD LEVEL; MALE; MENTAL STRESS; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTE RELEASE REACTION; TRIACYLGLYCEROL BLOOD LEVEL; URINARY EXCRETION;

EID: 2642640424     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615005     Document Type: Article

References (50)

1. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. New Engl J Med 1992; 326: 242-50.
2. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. New Engl J Med 1992; 326: 310-8.
3. Ross R. The pathogenesis of atherosclerosis. A perspective for the 1990s. Nature 1993; 362: 801-9.
4. Henry PD, Cabello OA, Chen C-H. Hypercholesterolemia and endothelial dysfunction. Curr Opinion Lipidol 1995; 6: 190-5.
5. Hassal DG, Owen JS, Bruckdorfer KR. The aggregation of isolated human platelets in the presence of lipoproteins and prostacyclin. Biochem J 1983; 216: 43-9.
6. Bröijersén A, Wallén NH, Vitols S, Larsson PT, Hjemdahl P. Autologous low density lipoprotein enhances platelet aggregability in whole blood, as measured by filtragometry in vitro. Platelets 1993; 4: 11-5.
7. Aviram M, Brook JG. Characterization of the effect of plasma lipoproteins on platelet function in vitro. Haemostasis 1983; 13: 344-50.
8. Carvalho ACA, Colman RW, Lees RS. Platelet function in hyperlipoproteinemia. N Engl J Med 1974; 290: 434-8.
9. Tremoli E, Maderna P, Colli S, Morazzoni G, Sirtori M, Sirtori CR. Increased platelet sensitivity and thromboxane B, formation in type-II hyperlipoproteinaemic patients. Eur J Clin Invest 1984; 14: 329-33.
10. Schrör K, Löbel P, Steinhagen-Thiessen E. Simvastatin reduces platelet thromboxane formation and restores normal platelet sensitivity against prostacyclin in type IIa hypercholesterolemia. Eicosanoids 1989; 2: 39-45.
11. 2 synthesis in type IIa hypercholesterolemic patients. Atherosclerosis 1989; 79:79-83.
12. Joist JH, Baker RK, Schonfeld G. Increased in vivo and in vitro platelet function in type II- and type IV-hyperlipoproteinemia. Thromb Res 1979; 15: 95-108.
13. Nordøy A, Brox JH, Holme S, Killie JE, Arvidsson Lenner R. Platelets and coagulation in patients with familial hypercholesterolemia (type IIa). Acta Med Scand 1983; 213: 129-35.
14. Lowe GDO, Drummond MM, Third JLHC, Bremner WF, Forbes CD, Prentice CRM, Lawrie TDV. Increased plasma fibrinogen and platelet-aggregates in type II hyperlipoproteinaemia. Thromb Haemost 1979; 42: 1503-7.
15. Goubran F, Maklady F, Saad M, El-Ashry M. In vivo platelet activity and lipoprotein patterns in coronary artery disease. Wien Klin Wochenschr 1986; 98: 209-11.
16. Wessels P, du Heynes AP, Esterhuysen AJ, Badenhorst PN, Louer MG, Pieters H, Kotzé HF. Kinetics and in vivo distribution of In-111-labelled platelets and platelet function in familial hypercholesterolemia. Thromb Haemost 1987; 58: 811-6.
17. Davi G, Averna M, Catalano I, Barbagallo CM, Ganci A, Notarbartolo A, Ciabattoni G, Patrono C. Increased thromboxane biosynthesis in type IIa hypercholesterolemia. Circulation 1992; 85: 1792-8.
18. Zahavi J, Betteridge JD, Jones NAG, Gallon DJ, Kakkar VV. Enhanced in vivo platelet release reaction and malondialdehyde formation in patients with hyperlipidemia. Am J Med 1981; 70: 59-64.
19. Pfuller SL, Hosseinzadeh P, Firkin BG, Howard MA, Hendrix LE, Booth P. Activation of platelet coagulant activities by formalin. Thromb Haemost 1978; 39: 546-8.
20. Files JC, Malpass TW, Yee EK, Ritchie JL, Harker LA. Studies of human platelet α-granule release in vivo. Blood 1981; 58: 607-18.
21. Beck O, Wallén NH, Bröijersén A, Larsson PT, Hjemdahl P. On the accurate determination of serotonin in human plasma. Biochem Biophys Res Comm 1993; 196: 260-6.
22. Markovitz JH, Matthews KA. Platelets and coronary heart disease: potential psychophysiologic mechanisms. Psychosom Med 1991; 53: 643-68.
23. Goldstein JL, Brown MS. Familial hypercholesterolemia. In: Metabolic Basis of Inherited Disease. Scriver CR et al., eds. New York: McGraw-Hill, 1989; 1215-50.
24. Grundy SM, Chait A, Brunzell JD. Familial combined hyperlipidemia workshop. Arteriosclerosis 1987; 7: 203-7.
25. Bröijersén A, Eriksson M, Larsson PT, Beck O, Berglund L, Angelin B, Hjemdahl P. Effects of selective LDL-apheresis and pravastatin therapy in platelet function in familial hypercholesterolaemia. Eur J Clin Invest 1994; 24: 488-98.
26. Bröijersén A, Eriksson M, Angelin B, Hjemdahl P. Gemfibrozil enhances platelet activity in patients with combined hyperlipoproteinemia. Arterioscler Thromb Vasc Biol 1995; 15: 121-7.
27. Bröijersén A, Eriksson M, Leijd B, Angelin B, Hjemdahl P. No influence of simvastatin treatment on platelet function in vivo in patients with hypercholesterolemia. Arterioscler Thromb Vasc Biol 1997; 17: 273-8.
28. Frankenhaeuser M, Mellis I, Rissler A, Björkvall C, Patkai P. Catecholamine excretion as related to cognitive and emotional reaction patterns. Psychosom Med 1968; 30: 109-20.
29. Freyschuss U, Hjemdahl P, Juhlin-Dannfelt A, Linde B. Cardiovascular and sympathoadrenal responses to mental stress: influence of β-blockade. Am J Physiol 1988; 255: H1443-H51.
30. Hornstra G, ten Hoor F. The filtragometer: a new device for measuring platelet aggregation in venous blood of man. Thromb Diath Haemorrh 1975; 34: 531-44.
31. Hjemdahl P, Perneby C, Theodorson E, Egberg N, Larsson PT. A new assay for β-thromboglobulin in urine. Thromb Res 1991; 64: 33-42.
32. 2: A method for monitoring thromboxane production in vivo. Prostaglandins 1986; 32: 741-67.
33. Carlson K. Lipoprotein fractionation. J Clin Pathol 1973; 26 (suppl. 5): 32-7.
34. Lopes-Virella MF, Stone P, Ellis S, Colwell JA. Cholesterol determination in high density lipoproteins separated by three different methods. Clin Chem 1977; 23: 882-4.
35. Hjemdahl P. Catecholamine measurements in plasma by high-performance liquid chromatography with electrochemical detection. Methods Enzymol 1987; 142: 521-34.
36. Vermylen C, de Vreker R, Verstrate M. A rapid enzymatic method for assay of fibrinogen fibrin polymerization time (FPT test). Clin Chim Acta 1963; 8: 418-24.
37. Meade TW, Vickers MV, Thompson SG, Stirling Y, Haines AP, Miller GJ. Epidemiological characteristics of platelet aggregability. Br Med J 1985; 290: 428-32.
38. Marguerie GA, Edgington TS, Plow EF. Interaction of fibrinogen with its platelet receptor as part of a multistep reaction in ADP induced platelet aggregation. J Biol Chem 1980; 255: 154-61.
39. Jovinge S, Hamsten A, Tornvall P, Proudler A, Båvenholm P, Ericsson C-G, Godsland I, de Faire U, Nilsson J. Evidence for a role of tumor necrosis factor-α in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease. Metabolism in press.
40. Moore KP, Sheron N, Ward P, Taylor GW, Alexander GJM, Williams R. Leukotriene and prostaglandin production after infusion of tumor necrosis factor in man. Eicosanoids 1991; 4: 115-8.
41. Pawlowski NA, Kaplan G, Hamill AL, Cohn ZA, Scott WA. Arachidonic acid metabolism by human monocytes. Studies with platelet-depleted cultures. J Exp Med 1983; 158: 393-412.
42. 2 synthase (cyclooxygenase) in human monocytes. J Biol Chem 1990; 265: 16737-40.
43. Held C, Hjemdahl P, Rehnqvist N, Wallén NH, Forslund L, Björkander I, Angelin B, Wiman B. Haemostatic markers, inflammatory parameters and lipids in male and female patients in the Angina Prognosis Study In Stockholm (APSIS). A comparison with healthy controls. J Int Med 1997; 241: 59-69.
44. Steele P, Rainwater J. Effects of dietary and pharmacological alteration of serum lipds on platelet survival time. Circulation 1978; 58: 365-7.
45. Notarbartolo A, Davi G, Averna M, Barbagallo CM, Ganci A, Giammarresi C, La Placa FP, Patrono C. Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia. Arterioscler Thromb Vasc Biol 1995; 15: 247-51.
46. Willich SN, Maclure M, Mittleman M, Arntz H-R, Muller JE. Sudden cardiac death: support for a role of triggering in causation. Circulation 1993; 87: 1442-50.
47. Levine SP, Towell BL, Suarez AM, Knieriem L-K, Harris MM, George JN. Platelet activation and secretion associated with emotional stress. Circulation 1985; 71: 1129-34.
48. Rostrup M, Mundal HH, Kjeldsen SE, Gjesdal K, Eide I. Awareness of high blood pressure stimulates platelet release reaction. Thromb Haemost 1990; 63: 367-70.
49. Mest H-J, Zehl U, Sziegoleit W, Taube C, Förster W. Influence of mental stress on plasma level of prostaglandins, thromboxane 62 and circulating platelet aggregates in man. Prostaglandins Leukotrienes Med 1982; 8: 553-63.
50. Austin MA. Plasma triglycerides and coronary heart disease. Arterioscler Thromb 1991; 11: 2-14.